| Name | Eganelisib(IPI-549) | CAS# | 1693758-51-8 | |
|---|---|---|---|---|
| Price | $500.0/100mg $950.0/250mg $1900.0/1g | Purity | 98.0% | |
| Stocking Period |
3 Day | Stock | 3 | |
| Product Webpage: | https://www.dcchemicals.com/product_show-IPI_549.html | |||
| Detail
Product Information
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits PI3K-gamma. |